Description
BOVI-TECT III
Reg. No. G3211 (Act 36/1947)
Namibia Reg. No. V03/24.4/684 [NS0]
INDICATIONS
The combination vaccine reduces the incidence of morbidity and mortality caused by undifferentiated bovine respiratory diseases (pasteurellosis) associated with M. (Pasteurella) haemolytica, BHV 1 (infectious bovine rhinotracheitis – IBR) and BVDV 1. This vaccine is recommended for inclusion in a vaccination programme of feedlot cattle at processing.
COMPOSITION
Mannheimia (Pasteurella) haemolytica biotype A serotype 1/17 cell-free supernatant leukotoxin vaccine for cattle, excluding dairy herds and pregnant animals, to be used in conjunction with modified live bovine herpes virus 1 (BHV 1) (IBR) and bovine virus diarrhoea virus 1 (BVDV 1), supplied in a separate smaller glass vial labeled Bovi-Tect III IBR/BVD component.
For optimum usage, consult your veterinarian.
